Patent details
EP2179744 Title: Decreasing potential latrogenic risks associated with influenza vaccines
Basic Information
- Publication number:
- EP2179744
- PCT Application Number:
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP090753773
- PCT Publication Number:
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- Decreasing potential latrogenic risks associated with influenza vaccines
- French Title of Invention:
- Diminution des risques iatrogènes potentiels associés aux vaccins contre la grippe
- German Title of Invention:
- Verminderung von potentiellen iatrogenen Risiken in Verbindung mit Influenza Impfstoffen
- SPC Number:
Dates
- Filing date:
- 09/09/2005
- Grant date:
- 01/12/2010
- EP Publication Date:
- 01/12/2010
- PCT Publication Date:
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 28/04/2010
- EP B1 Publication Date:
- 01/12/2010
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 09/09/2014
- Expiration date:
- 09/09/2025
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 09/09/2005
- Name:
- Novartis Vaccines and Diagnostics GmbH
- Address:
- Emil-von-Behring-Strasse 76, 35041 Marburg, Germany (DE)
Agent
- Name:
- OFFICE FREYLINGER S.A.
- From:
- 05/01/2011
- Address:
- Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
- To:
Inventor
- Name:
- Gregersen Jens Peter
- Address:
- Germany (DE)
Priority
- Priority Number:
- 04255471
- Priority Date:
- 09/09/2004
- Priority Country:
- European Patent Office (EPO) (EP)
Classification
- Main IPC Class:
- A61K 39/145;
| Filing date | Document type | Number of pages |
|---|